利润表（海正药业）
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 一、营业总收入(元) | 9,786,848,052.59 | 7,874,540,640.41 | 5,243,468,128.10 | 2,726,615,253.70 | 10,373,071,956.92 | 8,700,895,404.71 | 6,060,103,056.03 | 3,063,534,009.22 |
| 营业收入(元) | 9,786,848,052.59 | 7,874,540,640.41 | 5,243,468,128.10 | 2,726,615,253.70 | 10,373,071,956.92 | 8,700,895,404.71 | 6,060,103,056.03 | 3,063,534,009.22 |
| 二、营业总成本(元) | 9,027,322,865.05 | 7,323,584,992.31 | 4,907,475,802.86 | 2,578,018,340.82 | 10,134,419,762.12 | 8,114,926,469.04 | 5,564,001,745.74 | 2,778,135,602.12 |
| 营业成本(元) | 5,407,122,407.82 | 4,632,200,445.07 | 3,179,032,890.99 | 1,740,824,816.68 | 6,188,820,795.60 | 5,107,548,811.01 | 3,541,502,539.92 | 1,830,728,132.67 |
| 研发费用(元) | 357,688,684.68 | 262,633,894.43 | 177,546,214.57 | 89,183,595.29 | 391,953,184.73 | 311,379,461.10 | 210,712,020.46 | 97,041,933.90 |
| 营业税金及附加(元) | 107,827,516.90 | 77,046,271.19 | 43,918,631.60 | 26,911,175.38 | 84,942,223.31 | 59,771,906.04 | 33,002,412.56 | 23,767,446.02 |
| 销售费用(元) | 2,128,788,534.69 | 1,583,085,460.85 | 999,873,586.74 | 470,410,988.15 | 2,368,357,495.82 | 1,804,226,005.13 | 1,236,609,099.58 | 548,317,890.42 |
| 管理费用(元) | 896,955,589.19 | 667,223,152.78 | 434,579,174.80 | 212,740,662.21 | 908,672,800.91 | 683,261,527.15 | 439,720,628.18 | 222,386,372.59 |
| 财务费用(元) | 128,940,131.77 | 101,395,767.99 | 72,525,304.16 | 37,947,103.11 | 191,673,261.75 | 148,738,758.61 | 102,455,045.04 | 55,893,826.52 |
| 其中：利息费用(元) | 155,899,507.05 | 123,269,108.14 | 87,506,144.38 | 46,821,956.82 | 215,402,480.88 | 166,603,909.22 | 114,496,523.52 | 56,524,961.92 |
| 三、其他经营收益 | ||||||||
| 加：公允价值变动收益(元) | -14,926,284.66 | -13,227,309.09 | -116,840.31 | -21,808.83 | 278,292.28 | 1,398,660.11 | 163,740.03 | 1,547,057.58 |
| 加：投资收益(元) | 167,790,216.76 | 181,056,163.81 | 170,208,529.96 | 122,620,672.11 | 66,055,662.43 | 71,828,219.93 | 98,437,053.22 | 7,610,239.93 |
| 其中：对联营企业和合营企业的投资收益(元) | 5,201,926.21 | 32,632,836.23 | 19,549,930.39 | 13,387,124.38 | -60,372,967.29 | -42,891,349.57 | -17,561,687.17 | -15,865,690.79 |
| 资产处置收益(元) | 722,661.20 | 1,737,175.59 | 2,682,933.65 | -7,150.39 | -11,491,146.77 | -14,833,894.53 | -1,196,608.97 | 15,277,919.36 |
| 资产减值损失(元) | -219,020,280.63 | -186,768,005.60 | -72,741,345.86 | -32,274,913.03 | -285,521,664.88 | -83,680,794.86 | -84,633,429.90 | -17,797,649.97 |
| 信用减值损失(元) | -86,750,100.09 | -15,108,301.56 | -20,320,046.66 | -2,199,257.28 | -23,477,458.95 | -22,366,724.09 | -30,356,278.99 | -19,644,058.31 |
| 其他收益(元) | 113,992,631.02 | 87,779,410.47 | 72,365,112.45 | 36,166,575.74 | 104,947,092.26 | 73,344,380.76 | 53,772,416.01 | 23,370,830.13 |
| 四、营业利润(元) | 721,334,031.14 | 606,424,781.72 | 488,070,668.47 | 272,881,031.20 | 89,442,971.17 | 611,658,782.99 | 532,288,201.69 | 295,762,745.82 |
| 加：营业外收入(元) | 7,457,918.79 | 6,326,176.69 | 2,252,079.36 | 263,402.53 | 1,721,298.11 | 962,829.39 | 828,936.26 | 50,202.67 |
| 减：营业外支出(元) | 10,719,878.44 | 7,230,702.78 | 4,758,577.09 | 2,555,290.75 | 174,031,000.86 | 49,232,609.05 | 47,582,543.20 | 166,327.00 |
| 五、利润总额(元) | 718,072,071.49 | 605,520,255.63 | 485,564,170.74 | 270,589,142.98 | -82,866,731.58 | 563,389,003.33 | 485,534,594.75 | 295,646,621.49 |
| 减：所得税费用(元) | 126,760,200.90 | 95,235,241.44 | 51,534,699.81 | 24,239,150.13 | 14,148,229.93 | 105,189,648.40 | 69,700,395.68 | 54,114,396.98 |
| 六、净利润(元) | 591,311,870.59 | 510,285,014.19 | 434,029,470.93 | 246,349,992.85 | -97,014,961.51 | 458,199,354.93 | 415,834,199.07 | 241,532,224.51 |
| (一)按经营持续性分类 | ||||||||
| 持续经营净利润(元) | 591,311,870.59 | 510,285,014.19 | 434,029,470.93 | 246,349,992.85 | -97,014,961.51 | 458,199,354.93 | 415,834,199.07 | 241,532,224.51 |
| (二)按所有权归属分类 | ||||||||
| 归属于母公司股东的净利润(元) | 601,182,827.25 | 515,312,975.68 | 435,241,383.97 | 248,531,288.09 | -93,171,306.60 | 442,382,486.10 | 404,138,825.87 | 232,298,844.11 |
| 少数股东损益(元) | -9,870,956.66 | -5,027,961.49 | -1,211,913.04 | -2,181,295.24 | -3,843,654.91 | 15,816,868.83 | 11,695,373.20 | 9,233,380.40 |
| 扣除非经常性损益后的净利润(元) | 422,556,636.62 | 345,529,932.92 | 259,215,665.32 | 133,020,652.83 | -100,015,816.10 | 332,300,306.08 | 296,867,490.94 | 169,061,721.09 |
| 七、每股收益 | ||||||||
| 一、基本每股收益(元) | 0.52 | 0.44 | 0.37 | 0.21 | -0.08 | 0.38 | 0.35 | 0.19 |
| 二、稀释每股收益(元) | 0.52 | 0.44 | 0.37 | 0.21 | -0.08 | 0.38 | 0.32 | 0.17 |
| 八、其他综合收益(元) | 952,422.72 | -512,365.67 | -1,082,846.91 | -717,310.31 | 1,311,827.06 | 2,079,722.81 | 3,165,501.87 | -1,388,894.91 |
| 归属于母公司股东的其他综合收益(元) | 952,422.72 | -512,365.67 | -1,082,846.91 | -717,310.31 | 1,311,827.06 | 2,079,722.81 | 3,165,501.87 | -1,388,894.91 |
| 九、综合收益总额(元) | 592,264,293.31 | 509,772,648.52 | 432,946,624.02 | 245,632,682.54 | -95,703,134.45 | 460,279,077.74 | 418,999,700.94 | 240,143,329.60 |
| 归属于母公司所有者的综合收益总额(元) | 602,135,249.97 | 514,800,610.01 | 434,158,537.06 | 247,813,977.78 | -91,859,479.54 | 444,462,208.91 | 407,304,327.74 | 230,909,949.20 |
| 归属于少数股东的综合收益总额(元) | -9,870,956.66 | -5,027,961.49 | -1,211,913.04 | -2,181,295.24 | -3,843,654.91 | 15,816,868.83 | 11,695,373.20 | 9,233,380.40 |
| 公告日期 | 2025-03-29 | 2024-10-31 | 2024-08-20 | 2024-04-30 | 2024-04-30 | 2023-10-28 | 2023-08-22 | 2023-04-25 |
| 审计意见(境内) | 标准无保留意见 | - | - | - | 保留意见 | - | - | - |
| 原始财报文件下载 | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) |
| 上市前/上市后 |
| 报表类型 |
| 一、营业总收入(元) |
| 营业收入(元) |
| 二、营业总成本(元) |
| 营业成本(元) |
| 研发费用(元) |
| 营业税金及附加(元) |
| 销售费用(元) |
| 管理费用(元) |
| 财务费用(元) |
| 其中：利息费用(元) |
| 三、其他经营收益 |
| 加：公允价值变动收益(元) |
| 加：投资收益(元) |
| 其中：对联营企业和合营企业的投资收益(元) |
| 资产处置收益(元) |
| 资产减值损失(元) |
| 信用减值损失(元) |
| 其他收益(元) |
| 四、营业利润(元) |
| 加：营业外收入(元) |
| 减：营业外支出(元) |
| 五、利润总额(元) |
| 减：所得税费用(元) |
| 六、净利润(元) |
| (一)按经营持续性分类 |
| 持续经营净利润(元) |
| (二)按所有权归属分类 |
| 归属于母公司股东的净利润(元) |
| 少数股东损益(元) |
| 扣除非经常性损益后的净利润(元) |
| 七、每股收益 |
| 一、基本每股收益(元) |
| 二、稀释每股收益(元) |
| 八、其他综合收益(元) |
| 归属于母公司股东的其他综合收益(元) |
| 九、综合收益总额(元) |
| 归属于母公司所有者的综合收益总额(元) |
| 归属于少数股东的综合收益总额(元) |
| 公告日期 |
| 审计意见(境内) |
| 原始财报文件下载 |
Showing 1 to 43 of 43 entries